HEALTHCARE

IBTimes Logo

Miners pull FTSE down 0.3 pct; UK inflation due

Britain's leading shares were 0.3 percent lower early on Tuesday, retreating from a 12-month high set the previous session with investors staying on the sidelines ahead of UK inflation data and upcoming U.S. corporate earnings.

White House blasts health insurance sector report

IBTimes Logo
The White House Monday blasted a report from the health insurance industry that said Senate healthcare legislation would lead to increases in annual insurance premiums of as much as $4,000 by 2019.

Earnings hopes lift Europe stocks to near 3-week high

IBTimes Logo
European stocks were up 1.2 percent by midday on Monday, hitting a near three-week high, as forecast-beating results from Philips (PHG.AS) fuelled hopes over results ahead of this week's earnings from bellwethers.
IBTimes Logo

Obama vows to end restrictions on gays in military

President Barack Obama, speaking on the eve of a major gay-rights march, told gay supporters on Saturday he would fight for their causes and renewed a pledge to end restrictions on their service in the U.S. military.
More news
IBTimes Logo

U.S. jobless rate hits 26-year high of 9.8 percent

U.S. employers unexpectedly cut more jobs in September than in August, underscoring the fragility of the economy's recovery from its worst recession in 70 years as businesses remain cautious about the future.
IBTimes Logo

Big pharma jumps back into flu business

A dearth of new products, new technologies and fresh commitments by governments scrambling to protect their populations from pandemic threats have lured U.S. drugmakers back into the flu vaccine business.
IBTimes Logo

Americans willing to fund healthcare reform: poll

Most Americans would pay higher taxes to fund healthcare reforms that provide the best quality of care, but only a minority expects Washington to deliver it, according to a survey released on Wednesday.
IBTimes Logo

Senate panel rejects public healthcare option

A Senate panel on Tuesday rejected a government-run public insurance option as part of a broad healthcare overhaul, handing insurers an early victory and setting the stage for a long fight over one of the bill's most contentious issues.
IBTimes Logo

Canada outranks U.S. in healthcare report card

Canada outperforms the United States in health outcomes but is well behind global leaders like Japan in overall health of its population, a Canadian report released on Monday showed.
IBTimes Logo

Abbott, J&J strike deals, boost vaccines

The world's two largest diversified healthcare companies struck deals on Monday that will propel them into vaccines, a red-hot area for investors because of the pandemic flu threat and potential high profits for preventing other diseases.
IBTimes Logo

Abbott, J&J to bulk up in Europe, vaccines

U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday, aimed at securing vaccines and other products key to future growth.
IBTimes Logo

Heavy lifting ahead for Obama on diplomatic agenda

After his efforts at diplomacy on the international stage last week, President Barack Obama faces some particularly daunting foreign policy decisions about the Afghan war, a nuclear Iran and an elusive Middle East peace.
IBTimes Logo

Johnson & Johnson buys 18 pct stake in Crucell

U.S. diversified health care company Johnson & Johnson has bought an 18 percent stake in biotech firm Crucell for 302 million euros ($444 million) as part of a flu vaccine development deal, the Dutch company said on Monday.
IBTimes Logo

Abbott, Johnson & Johnson bulk up in Europe

U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday aimed at securing vaccines and other products key to future growth.
IBTimes Logo

Abbott to buy Solvay unit for $6.6 billion: sources

U.S. drugmaker Abbott Laboratories plans to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros), two sources familiar with the situation said on Sunday, with an announcement expected on Monday.
IBTimes Logo

Abbott to buy Solvay unit for $6.6 bln: sources

U.S. drugmaker Abbott Laboratories plans to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros), two sources familiar with the situation said on Sunday, with an announcement expected on Monday.
IBTimes Logo

Abbott to buy Solvay unit for $6.6 billion: source

U.S. drugmaker Abbott Laboratories is planning to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros) in cash, with an announcement expected in the next 24 hours, a source familiar with the situation said on Sunday.
IBTimes Logo

Massachusetts names Kirk to fill Kennedy Senate seat

Paul Kirk, a former Democratic National Committee chairman and a close friend of the late Senator Edward Kennedy, was named on Thursday as a temporary replacement for the liberal champion in the U.S. Senate.
IBTimes Logo

U.S. Senate panel rejects Republican healthcare moves

The Senate Finance Committee battled over insurance plans for seniors on Wednesday and rejected a Republican effort to delay a final vote on a broad healthcare overhaul as it slowly waded through a crush of amendments.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.